BACKGROUND: Tuberculosis (TB) has emerged as a serious public health problem in the country of Georgia. However, little or no data exist on rates and risk factors for drug-resistant TB, including multidrug-resistant (MDR)-TB, in Georgia. OBJECTIVE: To assess the prevalence and risk factors for drug-resistant TB. METHODS: A cross-sectional prospective survey of patients with suspected pulmonary TB was carried out at four sentinel sites (Tbilisi, Zugdidi, Kutaisi, and Batumi) in Georgia between January 1, 2001 and December 31, 2004. RESULTS: Among 1422 patients with suspected pulmonary TB, 996 (70.0%) were culture positive; 931/996 (93.5%) had drug susceptibility testing performed. Overall, 64.0% of patients (48.3% of new and 85.3% of retreatment cases) had positive cultures for Mycobacterium tuberculosis resistant to >or=1 first-line antituberculosis drugs. The overall prevalence of MDR-TB was 28.1% (10.5% of newly diagnosed patients and 53.1% of retreatment cases). In multivariate analysis, risk factors for MDR-TB included: being a retreatment case (prevalence ratio (PR)=5.28, 95% CI 3.95-7.07), history of injection drug use (PR=1.59, 95% CI 1.21-2.09), and female gender (PR=1.36, 95% CI 1.12-1.65). CONCLUSIONS: MDR-TB has emerged as a serious public health problem in Georgia and will greatly impact TB control strategies.
BACKGROUND:Tuberculosis (TB) has emerged as a serious public health problem in the country of Georgia. However, little or no data exist on rates and risk factors for drug-resistant TB, including multidrug-resistant (MDR)-TB, in Georgia. OBJECTIVE: To assess the prevalence and risk factors for drug-resistant TB. METHODS: A cross-sectional prospective survey of patients with suspected pulmonary TB was carried out at four sentinel sites (Tbilisi, Zugdidi, Kutaisi, and Batumi) in Georgia between January 1, 2001 and December 31, 2004. RESULTS: Among 1422 patients with suspected pulmonary TB, 996 (70.0%) were culture positive; 931/996 (93.5%) had drug susceptibility testing performed. Overall, 64.0% of patients (48.3% of new and 85.3% of retreatment cases) had positive cultures for Mycobacterium tuberculosis resistant to >or=1 first-line antituberculosis drugs. The overall prevalence of MDR-TB was 28.1% (10.5% of newly diagnosed patients and 53.1% of retreatment cases). In multivariate analysis, risk factors for MDR-TB included: being a retreatment case (prevalence ratio (PR)=5.28, 95% CI 3.95-7.07), history of injection drug use (PR=1.59, 95% CI 1.21-2.09), and female gender (PR=1.36, 95% CI 1.12-1.65). CONCLUSIONS: MDR-TB has emerged as a serious public health problem in Georgia and will greatly impact TB control strategies.
Authors: H T W Quy; N T N Lan; M W Borgdorff; J Grosset; P D Linh; L B Tung; D van Soolingen; M Raviglione; N V Cô; J Broekmans Journal: Int J Tuberc Lung Dis Date: 2003-07 Impact factor: 2.373
Authors: D M Weinstock; O Hahn; M Wittkamp; K A Sepkowitz; G Khechinashvili; H M Blumberg Journal: Int J Tuberc Lung Dis Date: 2001-02 Impact factor: 2.373
Authors: P Dewan; A Sosnovskaja; V Thomsen; J Cicenaite; K Laserson; I Johansen; E Davidaviciene; C Wells Journal: Int J Tuberc Lung Dis Date: 2005-02 Impact factor: 2.373
Authors: A Aerts; M Habouzit; L Mschiladze; N Malakmadze; N Sadradze; O Menteshashvili; F Portaels; P Sudre Journal: Int J Tuberc Lung Dis Date: 2000-12 Impact factor: 2.373
Authors: M A Espinal; S J Kim; P G Suarez; K M Kam; A G Khomenko; G B Migliori; J Baéz; A Kochi; C Dye; M C Raviglione Journal: JAMA Date: 2000-05-17 Impact factor: 56.272
Authors: D C Richards; T Mikiashvili; J J Parris; E V Kourbatova; J C E Wilson; N Shubladze; T Tsertvadze; G Khechinashvili; C del Rio; H M Blumberg Journal: Int J Tuberc Lung Dis Date: 2006-04 Impact factor: 2.373
Authors: S Lockman; A Kruuner; N Binkin; K Levina; Y Wang; M Danilovitsh; S Hoffner; J Tappero Journal: Clin Infect Dis Date: 2001-01-26 Impact factor: 9.079
Authors: M A Espinal; K Laserson; M Camacho; Z Fusheng; S J Kim; R E Tlali; I Smith; P Suarez; M L Antunes; A G George; N Martin-Casabona; P Simelane; K Weyer; N Binkin; M C Raviglione Journal: Int J Tuberc Lung Dis Date: 2001-10 Impact factor: 2.373
Authors: Russell R Kempker; Nestani Tukvadze; Lisa Sthreshley; Lisa Sharling; Dawn L Comeau; Matthew J Magee; Carlos Del Rio; Zaza Avaliani; Henry M Blumberg Journal: Am J Trop Med Hyg Date: 2018-02-01 Impact factor: 2.345
Authors: L Guglielmetti; C Hewison; Z Avaliani; J Hughes; N Kiria; N Lomtadze; N Ndjeka; S Setkina; A Shabangu; W Sikhondze; A Skrahina; N Veziris; J Furin Journal: Int J Tuberc Lung Dis Date: 2017-02-01 Impact factor: 2.373
Authors: Feng Yang; Hang Yu; Karthik Kantipudi; Manohar Karki; Yasmin M Kassim; Alex Rosenthal; Darrell E Hurt; Ziv Yaniv; Stefan Jaeger Journal: Quant Imaging Med Surg Date: 2022-01
Authors: E Green; C L Obi; M Nchabeleng; B E de Villiers; P P Sein; T Letsoalo; A A Hoosen; P O Bessong; R N Ndip Journal: J Health Popul Nutr Date: 2010-02 Impact factor: 2.000